Evotec SE (OTCMKTS:EVTCY - Get Free Report) shares passed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $3.86 and traded as high as $4.16. Evotec shares last traded at $4.12, with a volume of 192,035 shares trading hands.
Evotec Price Performance
The company has a market capitalization of $1.41 billion, a P/E ratio of 10.41 and a beta of 0.98. The company's 50-day moving average price is $3.93 and its two-hundred day moving average price is $4.10. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.57 and a quick ratio of 2.50.
About Evotec
(
Get Free Report)
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Featured Articles
Before you consider Evotec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evotec wasn't on the list.
While Evotec currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
